Shares of Bausch Health Companies (NYSE: BHC) were sinking by 8.6% as of 2:51 p.m. EDT on Tuesday. The decline came after Bausch Health announced that it had filed a lawsuit against Novartis (NYSE: NVS) subsidiary Sandoz, related to alleged infringement of patents for diarrhea drug Xifaxan.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,